Free Trial
→ Before you buy SpaceX shares, consider this alternative approach (From Weiss Ratings) (Ad)tc pixel Free BGLC Stock Alerts

BioNexus Gene Lab (BGLC) Short Interest Ratio & Short Volume

BioNexus Gene Lab logo
$1.98 0.00 (0.00%)
Closing price 03:56 PM Eastern
Extended Trading
$1.98 0.00 (0.00%)
As of 05:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

BioNexus Gene Lab Short Interest Overview

As of April 30, 2026, BioNexus Gene Lab (BGLC) had a short interest of 9,982 shares sold short, representing 0.41% of the public float. This marks a 0.14% increase in short interest since the prior report. The short interest ratio (days to cover) is 2.1, meaning it would take 2.1 days of the average trading volume of 4,293 shares to cover all short positions.

Current Short Interest
9,982 shares
Previous Short Interest
9,968 shares
Change Vs. Previous Month
0.14%
Dollar Volume Sold Short
$20.46 thousand
Short Interest Ratio
2.1 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
2,420,000 shares
Short Percent of Float
0.41%
Today's Trading Volume
13,331 shares
Average Trading Volume
4,293 shares
Today's Volume Vs. Average
311%
Short Selling BioNexus Gene Lab?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for BioNexus Gene Lab and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

BGLC Short Interest Over Time

BGLC Days to Cover Over Time

BGLC Percentage of Float Shorted Over Time

BioNexus Gene Lab Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20269,982 shares $20.46 thousand +0.1%0.4%2.1 $2.05
4/15/20269,968 shares $21.73 thousand -58.1%0.4%4.49 $2.18
3/31/202623,800 shares $51.07 thousand +4.7%1.0%3.74 $2.15
3/13/202622,737 shares $52.39 thousand -16.6%1.0%3.78 $2.30
2/27/202627,262 shares $74.15 thousand +65.0%1.2%2.65 $2.72
2/13/202616,524 shares $35.36 thousand -5.1%0.7%0.34 $2.14
1/30/202617,402 shares $44.39 thousand +2.1%0.7%0.39 $2.55
1/15/202617,038 shares $62.12 thousand -38.3%0.7%2.55 $3.65
12/31/202527,606 shares $113.60 thousand -31.4%1.2%1.87 $4.12
12/15/202540,210 shares $166.47 thousand +15.6%1.7%0.12 $4.14
11/28/202534,776 shares $157.54 thousand -46.3%1.5%2.82 $4.53
11/14/202564,704 shares $293.11 thousand +315.9%3.6%0.29 $4.53
10/31/202515,556 shares $84.31 thousand +1.3%0.9%0.11 $5.42
10/15/202515,400 shares $79.93 thousand -63.1%1.2%0 $5.19
9/30/202541,700 shares $228.10 thousand -73.5%3.3%0 $5.47
9/15/2025157,300 shares $789.65 thousand +206.0%12.4%0.1 $5.02
8/31/202551,400 shares $291.95 thousand -4.8%4.1%0 $5.68
8/15/202554,000 shares $288.36 thousand -92.3%4.3%0 $5.34
7/31/2025703,700 shares $4.88 million +1,737.3%55.4%0.4 $6.93
7/15/202538,300 shares $143.63 thousand +361.5%3.3%0 $3.75
6/30/20258,300 shares $25.48 thousand -47.8%0.7%0 $3.07
6/15/202515,900 shares $43.88 thousand -74.2%1.4%0 $2.76
5/31/202561,700 shares $268.40 thousand -3.0%5.3%0.1 $4.35
5/15/202563,600 shares $193.34 thousand +25.7%5.4%0.1 $3.04
4/30/202550,600 shares $144.21 thousand -82.6%4.4%0.1 $2.85
4/15/2025291,500 shares $772.48 thousand +150.4%26.5%0.5 $2.65
3/31/2025116,400 shares $275.17 thousand -50.2%6.5%1.4 $2.36
3/15/2025233,600 shares $81.76 thousand -36.2%2.1%0.1 $0.35
2/28/2025366,100 shares $119.90 thousand -1.4%3.0%0.1 $0.33
2/15/2025371,200 shares $137.72 thousand +18.3%3.1%0.1 $0.37
1/31/2025313,800 shares $127.87 thousand -61.7%2.7%0.1 $0.41
1/15/2025820,000 shares $287 thousand +131.6%7.0%0.2 $0.35
12/31/2024354,000 shares $99.01 thousand +79.6%3.0%0.1 $0.28
12/15/2024197,100 shares $51.27 thousand +164.6%1.7%0.3 $0.26
11/30/202474,500 shares $17.21 thousand -33.5%0.6%0.1 $0.23
11/15/2024112,100 shares $33.63 thousand -20.2%1.0%0.3 $0.30
10/31/2024140,400 shares $50.54 thousand +38.2%1.2%0.4 $0.36
10/15/2024101,600 shares $39.52 thousand -45.1%0.9%0.3 $0.39
9/30/2024185,200 shares $82.41 thousand -78.3%1.6%0.5 $0.45
9/15/2024852,200 shares $340.88 thousand +670.5%7.3%2.3 $0.40
I was right about SpaceX (Ad)

Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel

See how to claim your stake in SpaceX before the public can
8/31/2024110,600 shares $48.75 thousand +7.3%1.4%0.8 $0.44
8/15/2024103,100 shares $46.36 thousand -10.5%1.3%0.7 $0.45
7/31/2024115,200 shares $56.18 thousand -48.8%1.5%0.7 $0.49
7/15/2024224,800 shares $119.23 thousand +19.0%2.9%1.4 $0.53
6/30/2024188,900 shares $89.77 thousand +6.2%2.4%0.9 $0.48
6/15/2024177,900 shares $78.63 thousand +204.1%2.3%0.8 $0.44
5/31/202458,500 shares $24.85 thousand -44.8%0.7%0.3 $0.42
5/15/2024105,900 shares $61.43 thousand -40.0%1.3%0.5 $0.58
4/30/2024176,500 shares $109.41 thousand +77.0%2.5%0.1 $0.62
4/15/202499,700 shares $61.98 thousand +129.7%1.4%0.1 $0.62
3/31/202443,400 shares $30.64 thousand +115.9%0.6%0 $0.71
3/15/202420,100 shares $14.38 thousand -60.0%0.3%0 $0.72
2/29/202450,300 shares $28.27 thousand -94.6%0.7%0 $0.56
2/15/2024922,200 shares $1.05 million +885.3%12.1%0.3 $1.14
1/31/202493,600 shares $43.93 thousand No Change1.2%0 $0.47
7/15/202320,600 shares $22.25 thousand +4,020.0%N/A0 $1.08

BGLC Short Interest - Frequently Asked Questions

Short interest is the volume of BioNexus Gene Lab shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 9,982 shares of BGLC short. 0.41% of BioNexus Gene Lab's shares are currently sold short. Learn More on BioNexus Gene Lab's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BGLC shares currently have a short interest ratio of 2.1. Learn More on BioNexus Gene Lab's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.41% of BioNexus Gene Lab's floating shares are currently sold short.

BioNexus Gene Lab saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 9,982 shares, an increase of 0.1% from the previous total of 9,968 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.41% of BioNexus Gene Lab's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to BioNexus Gene Lab: Basel Medical Group Ltd (0.59%), Aclarion, Inc. (10.76%), Biorestorative Therapies, Inc. (2.93%), Mangoceuticals, Inc. (3.17%), Agape ATP Corporation (0.99%), NewGenIvf Group Limited (9.26%), Natera, Inc. (3.00%), Guardant Health, Inc. (10.23%), Fresenius Medical Care AG & Co. KGaA (0.26%), BrightSpring Health Services, Inc. (7.45%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling BGLC is an investing strategy that aims to generate trading profit from BioNexus Gene Lab as its price is falling. BGLC shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BioNexus Gene Lab occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BGLC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BGLC, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like BGLC:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:BGLC) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
One coin wired into Elon's vision
The SpaceX IPO is projected to raise $75 billion in a single day... When that happens, the insiders who cashed...
Crypto 101 Media | Sponsoredtc pixel
The system holding the dollar together is gone…
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
Millionaire warns: Move your money before May 15
Larry Benedict - the trader who generated $274 million in client profits and beat the S&P 500 by 18 times in 2...
Brownstone Research | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
What Expenses Can Be Deducted From Capital Gains Tax This Year?
Capital gains taxes can quietly erode investment returns - but the tax code offers legitimate ways to potentia...
SmartAsset | Sponsoredtc pixel